EP Patent

EP2065385A1 — Stable crystalline salt of (R)-3-fluorophenyl-3,4,5-trifluorobenzylcarbamic acid 1-azabiciyclo [2.2.2]oct-3-yl ester

Assigned to Laboratorios Salvat SA · Expires 2009-06-03 · 17y expired

What this patent protects

The present invention refers to a stable crystalline salt of ( R )-3-fluorophenyl- 3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester of formula (I) and its use as medicament, in particular for the treatment of urinary incontinence or other diseases involving g…

USPTO Abstract

The present invention refers to a stable crystalline salt of ( R )-3-fluorophenyl- 3,4,5-trifluorobenzylcarbamic acid 1-azabicyclo [2.2.2]oct-3-yl ester of formula (I) and its use as medicament, in particular for the treatment of urinary incontinence or other diseases involving genitourinary disorders.

Drugs covered by this patent

Patent Metadata

Patent number
EP2065385A1
Jurisdiction
EP
Classification
—
Expires
2009-06-03
Drug substance claim
No
Drug product claim
No
Assignee
Laboratorios Salvat SA
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.